Clinical features and long-term outcome of nephrotic syndrome associated with heterozygous NPHS1 and NPHS2 mutations

Clinical Journal of the American Society of Nephrology

Volumn 4, Issue 6, 2009, Pages 1065-1072

  Caridi, Gianluca ^a   Gigante, Maddalena ^b   Ravani, Pietro ^k   Trivelli, Antonella ^a   Barbano, Giancarlo ^a   Scolari, Francesco ^c   Dagnino, Monica ^a   Murer, Luisa ^d   Murtas, Corrado ^e   Edefonti, Alberto ^f   Allegri, Landino ^e   Amore, Alessandro ^g   Coppo, Rosanna ^g   Emma, Francesco ^h   De Palo, Tommaso ⁱ   Penza, Rosa ^j   Gesualdo, Loreto ^b   Ghiggeri, Gian Marco ^a  

^a G GASLINI INSTITUTE   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c Division of Nephrology   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^g REGINA MARGHERITA CHILDREN S HOSPITAL   (Italy)

^h BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

ⁱ Giovanni XXIII Hospital   (Italy)

^j UNIVERSITY OF BARI   (Italy)

^k UNIVERSITY OF CALGARY   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLOSPORIN A; GLUTAMINE; IMMUNOGLOBULIN M; LEUCINE; METHYLPREDNISOLONE; NEPHRIN; PODOCIN; PROLINE; STEROID; TACROLIMUS; MEMBRANE PROTEIN; SIGNAL PEPTIDE;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIALYSIS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; GENE MUTATION; GENETIC VARIABILITY; GLOMERULOSCLEROSIS; HETEROZYGOTE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; KIDNEY FUNCTION; MALE; MUTATIONAL ANALYSIS; NEPHROTIC SYNDROME; PREDICTION; PROBABILITY; SURVIVAL TIME; ADOLESCENT; CHILD; FOLLOW UP; GENETICS; INFANT; KAPLAN MEIER METHOD; MORTALITY; POINT MUTATION; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; HETEROZYGOTE; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIERS ESTIMATE; MALE; MEMBRANE PROTEINS; NEPHROTIC SYNDROME; POINT MUTATION;

EID: 69249231160     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03910808     Document Type: Article

References (30)

1. Kaplan JM, Kim SH, North KN, Rennke H, Correia LA, Tong HQ, Mathis BJ, Rodriguez-Perez JC, Allen PG, Beggs AH, Pollak MR: Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 24: 251-256, 2000
2. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome. Nat Genet 24: 349-354, 2000
3. Caridi G, Bertelli R, Di Duca M, Dagnino M, Emma F, Onetti Muda A, Scolari F, Miglietti N, Mazzucco G, Murer L, Carrea A, Massella L, Rizzoni G, Perfumo F, Ghiggeri GM: Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 14: 1278-1286, 2003
4. Caridi G, Bertelli R, Scolari F, Sanna-Cherchi S, Di Duca M, Ghiggeri GM: Podocin mutations in sporadic focal-segmental glomerulosclerosis occurring in adulthood. Kidney Int 64: 365, 2003
5. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F: Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15: 722-732, 2004
6. Weber S, Gribouval O, Esquivel EL, Moriniere V, Tete MJ, Legendre C, Niaudet P, Antignac C: NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence. Kidney Int 66: 571-579, 2004
7. Beltcheva O, Martin P, Lenkkeri U, Tryggvason K: Mutation spectrum in the nephrin gene (NPHS1) in congenital nephrotic syndrome. Hum Mutat 17: 368-373, 2001
8. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, Mc-Cready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1: 575-582, 1998
9. Hinkes B, Vlangos C, Heeringa S, Mucha B, Gbadegesin R, Liu J, Hasselbacher K, Ozaltin F, Hildebrandt F: Specific podocin mutations correlate with age of onset in steroid-resistant nephrotic syndrome. J Am Soc Nephrol 19: 365-371, 2008
10. Mucha B, Ozaltin F, Hinkes BG, Hasselbacher K, Ruf RG, Schultheiss M, Hangan D, Hoskins BE, Everding AS, Bog-danovic R, Seeman T, Hoppe B, Hildebrandt F: Mutations in the Wilms' tumor 1 gene cause isolated steroid resistant nephrotic syndrome and occur in exons 8 and 9. Pediatr Res 59: 325-331, 2006
11. Lahdenkari AT, Kestila M, Holmberg C, Koskimies O, Jalanko H: Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS). Kidney Int 65: 1856-1863, 2004
12. Patrakka J, Martin P, Salonen R, Kestila M, Ruotsalainen V, Mannikko M, Ryynanen M, Rapola J, Holmberg C, Tryg-gvason K, Jalanko H: Proteinuria and prenatal diagnosis of congenital nephrosis in fetal carriers of nephrin gene mutations. Lancet 359: 1575-1577, 2002
13. Caridi G, Perfumo F, Ghiggeri GM: NPHS2 (Podocin) mutations in nephrotic syndrome: Clinical spectrum and fine mechanisms. Pediatr Res 57: 54R-61R, 2005
14. Heeringa SF, Vlangos CN, Chernin G, Hinkes B, Gbadegesin R, Liu J, Hoskins BE, Ozaltin F, Hildebrandt F: Thirteen novel NPHS1 mutations in a large cohort of children with congenital nephrotic syndrome. Nephrol Dial Transplant 23: 1455-1460, 2008
15. McKenzie LM, Hendrickson SL, Briggs WA, Dart RA, Korbet SM, Mokrzycki MH, Kimmel PL, Ahuja TS, Berns JS, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Cho M, Zhou YC, Binns-Roemer E, Kirk GD, Kopp JB, Winkler CA: NPHS2 variation in sporadic focal segmental glomerulosclerosis. J Am Soc Nephrol 18: 2987-2995, 2007
16. Tonna SJ, Needham A, Polu K, Uscinski A, Appel GB, Falk RJ, Katz A, Al-Waheeb S, Kaplan BS, Jerums G, Savige J, Harmon J, Zhang K, Curhan GC, Pollak MR: NPHS2 variation in focal and segmental glomerulosclerosis. BMC Nephrol 9: 13, 2008
17. Haltia A, Solin ML, Holmberg C, Reivinen J, Miettinen A, Holthofer H: Morphologic changes suggesting abnormal renal differentiation in congenital nephrotic syndrome. Pediatr Res 43: 410-414, 1998
18. Liapis H: Molecular pathology of nephrotic syndrome in childhood: A contemporary approach to diagnosis. Pediatr Dev Pathol 11: 154-163, 2008
19. ISKDC: Prospective, controlled trial of cyclophosphamide therapy in children with nephrotic syndrome: Report of the International study of Kidney Disease in Children. Lancet 2: 423-427, 1974
20. ISKDC: Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity: A report of the International Study of Kidney Disease in Children. Kidney Int 20: 765-771. 1981
21. Lenkkeri U, Mannikko M, McCready P, Lamerdin J, Gribouval O, Niaudet PM, Antignac CK, Kashtan CE, Homberg C, Olsen A, Kestila M, Tryggvason K: Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 64: 51-61, 1999
22. Caridi G, Bertelli R, Carrea A, Di Duca M, Catarsi P, Artero M, Carraro M, Zennaro C, Candiano G, Musante L, Seri M, Ginevri F, Perfumo F, Ghiggeri GM: Prevalence, genetics, and clinical features of patients carrying podocin mutations in steroid-resistant nonfamilial focal segmental glomerulosclerosis. J Am Soc Nephrol 12: 2742-2746, 2001
23. Gigante M, Monno F, Roberto R, Laforgia N, Assael MB, Livolti S, Caringella A, La Manna A, Masella L, Iolascon A: Congenital nephrotic syndrome of the Finnish type in Italy: A molecular approach. J Nephrol 15: 696-702, 2002
24. Aucella F, Bisceglia L, De Bonis P, Gigante M, Caridi G, Barbano G, Mattioli G, Perfumo F, Gesualdo L, Ghiggeri GM: WT1 mutations in nephrotic syndrome revisited: High prevalence in young girls, associations and renal phenotypes. Pediatr Nephrol 21: 1393-1398, 2006
25. Di Duca M, Oleggini R, Sanna-Cherchi S, Pasquali L, Di Donato A, Parodi S, Bertelli R, Caridi G, Frasca G, Cerullo G, Amoroso A, Schena FP, Scolari F, Ghiggeri GM: Cis and trans regulatory elements in NPHS2 promoter: Implications in proteinuria and progression of renal diseases. Kidney Int 70: 1332-1341, 2006
26. Franceschini N, North KE, Kopp JB, McKenzie L, Winkler C: NPHS2 gene, nephrotic syndrome and focal segmental glomerulosclerosis: A HuGE review. Genet Med 8: 63-75, 2006
27. Ghiggeri GM, Catarsi P, Scolari F, Caridi G, Bertelli R, Carrea A, Sanna-Cherchi S, Emma F, Allegri L, Cancarini G, Rizzoni GF, Perfumo F: Cyclosporine in patients with steroid-resistant nephrotic syndrome: An open-label, nonrandomized, retrospective study. Clin Ther 26: 1411-1418, 2004
28. Nishibori Y, Liu L, Hosoyamada M, Endou H, Kudo A, Takenaka H, Higashihara E, Bessho F, Takahashi S, Kershaw D, Ruotsalainen V, Tryggvason K, Khoshnoodi J, Yan K: Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney Int 66: 1755-1765, 2004
29. Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, Schachter AD, Poch E, Abreu PF, Appel GB, Pereira AB, Kalluri R, Pollak MR: NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 110: 1659-1666, 2002
30. Pereira AC, Pereira AB, Mota GF, Cunha RS, Herkenhoff FL, Pollak MR, Mill JG, Krieger JE: NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 65: 1026-1030, 2004